Skip to main content
Fig. 4 | Antimicrobial Resistance & Infection Control

Fig. 4

From: Cost-effectiveness of strategies to control the spread of carbapenemase-producing Enterobacterales in hospitals: a modelling study

Fig. 4

Cost-effectiveness acceptability curves for strategies. They represent the probability of each strategy to be cost-effective at different values of willingness to pay for a CPE case avoided. Strategies: (1) Targeted screening (TS) + contact precautions (CP) without isolation of carriers in single room, (2) TS + CP + single room, (3) TS + dedicated nursing staff (DNS) + single room, (4) Universal screening (US) + CP without isolation in single room, (5) US + CP + single room, (6) US + DNS + single room, (7) TS + CP + without isolation of carriers in single room + weekly screening of contact patients (WSC), (8) TS + CP + single room + WSC, (9) TS + DNS + single room + WSC, (10) US + CP without isolation in single room + WSC, (11) US + CP + single room + WSC, (12) US + DNS + single room + WSC

Back to article page